http://www.pharmexec.com/pharmexec/PharmExec+Direct+Marketing+Edition/Article/list/39871 The publisher of Pharmaceutical Executive brings visitors PharmExec.com, which serves up a daily dose of news and features from the world of pharma business and marketing. 2013-05-22T05:57:11Z http://www.pharmexec.com/pharmexec/Marketing+News/GSK-Chooses-MediaCom-for-a-Billion-Dollar-Planner-/ArticleStandard/Article/detail/480056?contextCategoryId=39871&ref=25 GlaxoSmithKline locks up MediaCom as its only ad-buying/planning provider. The agency will handle GSK's massive ad spend, which last year hovered around $1.1 billion. 2007-12-18T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/512007/480056null HTML http://www.pharmexec.com/pharmexec/Marketing+News/Vertex-Pharmaceuticals-Brings-Transparency-Online/ArticleStandard/Article/detail/480057?contextCategoryId=39871&ref=25 Drug manufacturer shakes things up with new Web site that functions as an open book into the world of Vertex Pharmaceuticals. The company hopes that its transparent approach to design will be a lesson to pharma companies still fearful of online media. 2007-12-18T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/512007/480057null HTML http://www.pharmexec.com/pharmexec/Legal/Arkansas-Attorney-General-Takes-JampJ-to-Task/ArticleStandard/Article/detail/477264?contextCategoryId=39871&ref=25 The State of Arkansas filed suit against Risperdal manufacturer Johnson & Johnson, claiming promotion of the drug for nonmedical uses has led to increased prescriptions being written and bigger payouts by Medicaid. 2007-12-05T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/492007/477264null HTML http://www.pharmexec.com/pharmexec/News+Analysis/In-Defense-of-Peer-Review-Waxman-Opponents-Argue-f/ArticleStandard/Article/detail/477262?contextCategoryId=39871&ref=25 Peer-review advocates speak out against Congressman Waxman?s stance on a new policy that would allow pharma to distribute unbiased journal articles to doctors without prior approval. 2007-12-05T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/492007/477262null HTML http://www.pharmexec.com/pharmexec/PharmExec+Direct+Marketing+Edition/Doc-Driven-Search-Site-Lists-Top-Search-Terms/ArticleStandard/Article/detail/474121?contextCategoryId=39871&ref=25 A physician-oriented search engine reveals its most-searched terms. Among the winners: breast and lung cancer, cortisol, and HbA1c/glycated hemoglobin. Nowhere to be seen: pharmaceutical products. 2007-11-21T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/472007/474121null HTML http://www.pharmexec.com/pharmexec/PharmExec+Direct+Marketing+Edition/Discovery-Health-Documentary-Spotlights-Diabetes-a/ArticleStandard/Article/detail/474128?contextCategoryId=39871&ref=25 A new pharma-sponsored documentary chronicles one doctor?s adventure around the world as she searches for stories about living with diabetes. The program, sponsored by Novo Nordisk, enlightens viewers and offers physicians a chance to earn one AMA-approved CME credit. 2007-11-21T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/472007/474128null HTML http://www.pharmexec.com/pharmexec/PharmExec+Direct+Marketing+Edition/GSK-Told-to-Update-Avandia-Warnings/ArticleStandard/Article/detail/474124?contextCategoryId=39871&ref=25 Faced with contradictory data about the safety of the diabetes treatment, FDA asks for a black-box warning and additional trials. But how much damage will the black box do? 2007-11-21T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/472007/474124null HTML http://www.pharmexec.com/pharmexec/News+Analysis/Lillys-New-Blood-Thinner-No-Blockbuster/ArticleStandard/Article/detail/470634?contextCategoryId=39871&ref=25 Safety Risks, Generic Threat Scale Down Big Hopes 2007-11-06T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/452007/470634null HTML http://www.pharmexec.com/pharmexec/News+Analysis/Stormy-Forecast-for-Pharma-in-2008/ArticleStandard/Article/detail/470632?contextCategoryId=39871&ref=25 Bright Spots Are Emerging Markets, Specialty Drugs, Says IMS Health 2007-11-06T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/452007/470632null HTML http://www.pharmexec.com/pharmexec/News+Analysis/About-face-for-Avandia/ArticleStandard/Article/detail/470623?contextCategoryId=39871&ref=25 Avandia continues on its sales slide. Generic metformin reigns supreme, while Actos and Januvia battle for second place. 2007-11-06T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/452007/470623null HTML http://www.pharmexec.com/pharmexec/News+Analysis/Text-Against-AIDS/ArticleStandard/Article/detail/477263?contextCategoryId=39871&ref=25 HHS and Kaiser Family Foundation leverage phone texting technology to help people locate their nearest HIV/AIDS testing facility. Although slow to be adopted by the pharma industry, text marketing is becoming a useful tool to send health information directly to patients. 2007-11-05T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/492007/477263null HTML http://www.pharmexec.com/pharmexec/News+Analysis/Pfizer-Goes-Digital-with-Sermo-Partnership/ArticleStandard/Article/detail/467435?contextCategoryId=39871&ref=25 Pfizer named first pharmaceutical sponsor of social-networking community custom tailored for physicians and healthcare providers. Sermo CEO Daniel Palestrant explains how the deal will work. 2007-10-24T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/432007/467435null HTML http://www.pharmexec.com/pharmexec/News+Analysis/Massive-Layoffs-in-MarketingSales-Division-at-Nova/ArticleStandard/Article/detail/467425?contextCategoryId=39871&ref=25 Novartis forced to cut 1,260 jobs due to dwindling pipeline, Zelnorm withdrawal. The company also adds new pharmaceutical division head. 2007-10-24T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/432007/467425null HTML http://www.pharmexec.com/pharmexec/News+Analysis/Johnson-amp-Johnson-Markets-Drug-Stents-to-Consume/ArticleStandard/Article/detail/467420?contextCategoryId=39871&ref=25 Cordis, the medical-device arm of J&J, took out full-page ads last week to publicize their drug-eluting stents. 2007-10-24T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/432007/467420null HTML http://www.pharmexec.com/pharmexec/News+Analysis/Eli-Lilly-Sends-Two-Warning-Lettersmdashand-Gets-O/ArticleStandard/Article/detail/464037?contextCategoryId=39871&ref=25 Drug company releases two Dear Doctor Letters notifying physicians of updated warning labels for Zyprexa and Symbyax, and receives a letter from FDA for false advertising in a Cymbalta campaign. 2007-10-10T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/412007/464037null HTML http://www.pharmexec.com/pharmexec/News+Analysis/Microsoft-Launches-Healthcare-Search-Site/ArticleStandard/Article/detail/464035?contextCategoryId=39871&ref=25 New search engine gives consumers the ability to manage all their health needs from a central location--and offers pharma the opportunity to reach new patients through targeted search ads 2007-10-10T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/412007/464035null HTML http://www.pharmexec.com/pharmexec/News+Analysis/AstraZeneca-Spurs-Breast-Cancer-Awareness-with-Pap/ArticleStandard/Article/detail/464036?contextCategoryId=39871&ref=25 New Web site allows users to create tribute dolls for breast cancer survivors. For every doll made, AZ will donate $1 to charity. 2007-10-10T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/412007/464036null HTML http://www.pharmexec.com/pharmexec/News+Analysis/New-York-Sues-Merck-Over-False-Advertising-Claims/ArticleStandard/Article/detail/460057?contextCategoryId=39871&ref=25 New York State wants restitution for Vioxx 2007-09-26T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/392007/460057null HTML http://www.pharmexec.com/pharmexec/News+Analysis/PDUFA-Passed-with-Refined-DTC-Component/ArticleStandard/Article/detail/460045?contextCategoryId=39871&ref=25 FDA gains power to review ads and levy fines for misleading material 2007-09-26T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/392007/460045null HTML http://www.pharmexec.com/pharmexec/News+Analysis/Google-Unveils-New-Gadget-Ads/ArticleStandard/Article/detail/460052?contextCategoryId=39871&ref=25 Search engine giant says industry lags behind on e-marketing 2007-09-26T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/392007/460052null HTML http://www.pharmexec.com/pharmexec/News+Analysis/Where-Did-the-Viagra-Spam-Come-From-This-Time-From/ArticleStandard/Article/detail/456305?contextCategoryId=39871&ref=25 Pfizer computers infiltrated by spammers 2007-09-12T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/372007/456305null HTML http://www.pharmexec.com/pharmexec/News+Analysis/Feds-Preempt-State-in-Pharma-Ad-Fraud-Case/ArticleStandard/Article/detail/456308?contextCategoryId=39871&ref=25 Pharm ads green-lit by FDA can?t be sued for fraud in Delaware 2007-09-12T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/372007/456308null HTML http://www.pharmexec.com/pharmexec/News+Analysis/Microsoft-vs-Google-Web-War-20/ArticleStandard/Article/detail/456316?contextCategoryId=39871&ref=25 Two Internet superpowers are invading online consumer-health territory. What does it mean for pharma? 2007-09-12T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/372007/456316null HTML http://www.pharmexec.com/pharmexec/Marketing+News/Marketing-Blues-for-SSRIs/ArticleStandard/Article/detail/438924?contextCategoryId=39871&ref=25 Blockbuster antidepressants linked to bone loss in seniors 2007-07-03T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/272007/438924null HTML http://www.pharmexec.com/pharmexec/Marketing+News/Mercks-Not-So-New-Marketing-Model/ArticleStandard/Article/detail/438930?contextCategoryId=39871&ref=25 Or: No news is good news--for everyone but us reporters 2007-07-03T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/272007/438930null HTML